Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
China Literature to Report First Half 2024 Financial Results on August 12, 2024 2024-07-22 19:05
Gan & Lee Pharmaceuticals' Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial 2024-07-22 19:00
OMNICOM MEDIA GROUP AGENCIES OUTPERFORM FOR GROWTH ACROSS ALL FOUR REGIONS 2024-07-22 19:00
Daqo New Energy Announces $100 Million Share Repurchase Program 2024-07-22 18:30
DIVIDEND ALERT: US$1.098 CASH DIVIDEND TO BE DISTRIBUTED TO ChipMOS ADS HOLDERS PRE-WITHHOLDING TAX AND FEES 2024-07-22 18:00
Clarivate Acquires Rowan TELS to Enhance Support for Patent Practitioners 2024-07-22 18:00
China Unicom Voted as "Asia's Most Honored Telecom Company" for the Ninth Consecutive Year 2024-07-22 17:00
Japan Takes Gold in Most Searches for Paris - Agoda 2024-07-22 16:20
From Struggles to Triumph: Weichai's Engine Technology Boosts Malaysian Fishing Vessels' Efficiency by 43% 2024-07-22 16:07
FinVolution Publishes Sixth Annual ESG Report 2024-07-22 15:00
Kylian Mbappé and Accor Forge Alliance to Empower Younger Generations 2024-07-22 14:00
EHang Partners with KC Smart Mobility to Advance EH216-S Pilotless eVTOL Sale and Operation in Hong Kong and Macau 2024-07-22 13:21
Sohu.com to Report Second Quarter 2024 Financial Results on August 5, 2024 2024-07-22 13:00
Ping An Again Selected for S&P Global's Sustainability Yearbook (China Edition), the Sole Mainland Insurance Company 2024-07-22 12:32
TCL Electronics (01070.HK) Achieves 13% YoY Growth in Global TV Shipment in Q2 2024 2024-07-22 09:59
Agilent Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit 2024-07-22 09:12
Everest Medicines Announces First Chinese Patient Dosed in Global Phase 2b PALIZADE Trial of Zetomipzomib in Lupus Nephritis 2024-07-22 09:00
LG Display's OLED TV panels proven to be 'sleep friendly' supporting body and eye health 2024-07-22 09:00
ATIF Signs Two New Listing Advisory Agreements 2024-07-22 08:31
Innovent Announces the Second Phase 3 Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA 2024-07-22 08:00
1 113 114 115 116 117 3396